Complestain, a potent anti-complement substance produced by Streptomyces lavendulae. I. Fermentation, isolation and biological characterization.
- 1 January 1989
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 42 (2) , 236-241
- https://doi.org/10.7164/antibiotics.42.236
Abstract
A new potent inhibitor of complement system, named complestatin, was isolated from the mycelium of Streptomyces lavendulae SANK 60477. Complestatin (C61H45N7O15Cl6, MW 1,325) was a peptide compound having two unusual amino acids, D-(-)-4-hydroxyphenylglycine and D-(-)-3,5-dichloro-4-hydroxyphenylglycine. This compound inhibited the hemolysis of sensitized sheep erythrocytes (EA) mediated by guinea pig and human complement 50% at concentrations of 0.4 and 0.7 .mu.g/ml, respectively, but did not trypsin and .alpha.-chymotrypsin activities at 200 .mu.g/ml. When complestatin was administered intravenously to the sensitized guinea pigs, it strongly inhibited the systemic anaphylactic shock elicited by the antigen probably by blocking generation of anaphylatoxins (C3a and C5a).This publication has 7 references indexed in Scilit:
- Chloropolysporins A, B and C, novel glycopeptide antibiotics from Faenia interjecta sp. nov. II. Fermentation, isolation and physico-chemical characterization.The Journal of Antibiotics, 1987
- Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.Journal of Clinical Investigation, 1983
- New synthetic inhibitors of C1r̄, C1 esterase, thrombin, plasmin, kallikrein and trypsinBiochimica et Biophysica Acta (BBA) - Enzymology, 1981
- Leupeptin inhibits the C3/5 convertase CVFBb of the complement systemBiochimica et Biophysica Acta (BBA) - Enzymology, 1981
- Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: Evidence of a modulator role for the oligosaccharide unit in human des-Arg 74 -C5aProceedings of the National Academy of Sciences, 1981
- Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.The Journal of Immunology, 1980
- Pancreatic trypsin inhibitor. 1. Preparation and propertiesBiochemical Journal, 1953